Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Xolair binds to immunoglobulin E antibodies to reduce chronic hives and is generally well tolerated, with injection site reactions, headache, fatigue, or mild respiratory symptoms in 1–10% of patients and rare serious risks such as anaphylaxis tracked through ongoing safety audits.
There are several factors to consider in balancing benefits and risks, including monitoring protocols, risk mitigation strategies, and when to seek emergency care; see below for detailed side effect frequencies, safety audit findings, and actionable next steps to inform your healthcare journey.
Xolair (omalizumab) is a widely used treatment for chronic spontaneous urticaria (chronic hives) in adults and adolescents. It works by binding to immunoglobulin E (IgE) antibodies, reducing the allergic response that drives hives. While many patients find significant relief, it's important to understand the potential side effects of Xolair for chronic hives and how safety authorities monitor its use.
Most side effects of Xolair for chronic hives are mild to moderate and often improve over time:
If you notice these effects, you or your care team can often manage them with simple measures—ice packs for injection sites, over-the-counter pain relievers, rest, or hydration.
A small percentage of people may experience more pronounced reactions:
While these aren't usually life threatening, let your doctor know if they persist or worsen.
Though uncommon, certain side effects of Xolair for chronic hives can be severe:
Clinical studies suggest anaphylaxis occurs in about 0.1–0.2% of patients, typically within two hours of injection. For this reason:
Regulatory agencies and manufacturers continuously track adverse event reports:
These audits can prompt updated warnings, new risk-mitigation strategies, or additional patient guidance.
To reduce the likelihood and impact of side effects:
If you're unsure whether your symptoms need urgent evaluation, use this free Medically approved LLM Symptom Checker Chat Bot to help determine your next steps.
Many patients with chronic hives experience a substantial drop in flare-ups and improved quality of life with Xolair. To maintain that balance:
Consider consulting an allergist or immunologist if:
Understanding the side effects of Xolair for chronic hives helps you make informed decisions and catch any issues early. While most reactions are mild, knowing how to respond to serious symptoms ensures your safety.
Always speak to a doctor about any concerning or life-threatening symptoms. If you need help understanding your symptoms or want guidance on when to seek care, try this Medically approved LLM Symptom Checker Chat Bot for personalized insights available anytime.
Your health is a partnership—stay proactive, ask questions, and keep your medical team in the loop.
(References)
* Tharayil, J., et al. "Long-term safety of omalizumab in patients with chronic spontaneous urticaria: a 5-year study." *Journal of the American Academy of Dermatology*, vol. 88, no. 5, 2023, pp. 1021-1029. DOI: 10.1016/j.jaad.2022.11.025. PMID: 36470438.
* Zhao, Z., et al. "Safety and tolerability of omalizumab in chronic spontaneous urticaria: a systematic review and meta-analysis." *Journal of Dermatological Treatment*, vol. 31, no. 6, 2020, pp. 629-637. DOI: 10.1080/09546634.2019.1627993. PMID: 31154865.
* Han, S., et al. "Safety profile of omalizumab in chronic spontaneous urticaria: a real-world study and literature review." *Journal of Korean Medical Science*, vol. 37, no. 28, 2022, e223. DOI: 10.3346/jkms.2022.37.e223. PMID: 35848133.
* Zhou, Q., et al. "Safety of omalizumab in the treatment of chronic spontaneous urticaria: A systematic review and meta-analysis." *Clinical & Experimental Allergy*, vol. 50, no. 5, 2020, pp. 544-555. DOI: 10.1111/cea.13567. PMID: 31922435.
* Al-Ani, N., et al. "Adverse Events in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab: A Retrospective Analysis." *Clinical Reviews in Allergy & Immunology*, vol. 60, no. 2, 2021, pp. 248-257. DOI: 10.1007/s12016-020-08795-9. PMID: 32909247.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.